Duffy Sean P. sold $264K of OMDA
Duffy Sean P. (Chief Executive Officer) sold 12,944 shares of Omada Health, Inc. (OMDA) at $20.40 ($0.26M total) on 2026-08-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the CEO’s open-market sale details (shares, price, total value) and that it was executed under a 10b5-1 plan.
Market read
Traders may note insider selling, but the 10b5-1 designation typically reduces interpretive weight versus unscheduled sales.
What to watch
The article does not state whether other insiders sold, whether the CEO’s total position changed materially over time, or whether there were concurrent company-specific catalysts.
Background
The article is a SEC Form 4 insider transaction disclosure for Omada Health, Inc.
Ticker impact
Omada Health CEO Sean Duffy sold 12,944 shares in an open-market transaction at $20.3961 on 2026-08-03 under a 10b5-1 plan.
Limited near-term impact; any reaction is likely muted and short-lived.
The filing is a Form 4 insider transaction with a stated 10b5-1 pre-arranged plan, and it provides no new company fundamentals, guidance, or regulatory/legal developments.
Market effects
No clear sector read-through from a single 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations.
Key entities
- issuerOmada Health, Inc.
Company whose CEO insider sale is disclosed on Form 4.
- insiderSean P. Duffy
CEO and director who sold shares in an open-market transaction under a 10b5-1 plan.
